From the *David Geffen UCLA School of Medicine, Los Angeles, CA
†Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
‡Child and Adolescent Psychiatry and Psychotherapy, University Medical Center Goettingen and Leibniz Science Campus Primate Cognition, Goettingen, Germany
§iDN—interdisciplinary Developmental Neuroscience, Division of Phoniatrics, Medical University of Graz, Graz, Austria
¶Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
∥London School of Hygiene & Tropical Medicine, London, United Kingdom.
Accepted for publication September 19, 2021
Global Health Program at David Geffen UCLA School of Medicine, NIAID (AI28697, AI1259534, and AI140718), National Eye Institute grants (AI129847), Thrasher foundation, Brazil’s National Council of Scientific and Technological Development (441098/2016-9 and 305090/2016-0), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (441098/2016-9 and 305090/2016-0), Wellcome Trust and the United Kingdom’s Department for International Development (205377/Z/16/Z), European Union’s Horizon 2020 Research and Innovation Programme ZikaPLAN (734584).
The authors have no conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com)
Address for correspondence: Sophia Finn Tiene, BS, David Geffen UCLA School of Medicine, 10647 Wilkins Ave, Apt. 203, Los Angeles, CA 90024. E-mail: [email protected].
